PTK2 and neoplasm: Molecular and cellular mechanisms of FAK action on both tumor and stromal cell biology, regulation of its activity, and FAK-targeted anticancer therapeutic strategies that are, nowadays, under preclinical and clinical development have been extensively reviewed in different excellent review articles [1,2,3,4].